Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Jul-Sep;45(3):263-271.
doi: 10.12865/CHSJ.45.03.03. Epub 2019 Sep 30.

Clinical Aspects of Pterygium in the Presence of Cataract

M F Mercuţ Nicolcescu  1 , Ș Crăiţoiu  1 , C L Mocanu  1 , A Ştefănescu-Dima  1 , A Bălăşoiu  1 , R Mercuţ  2 , A G Ionescu  3 , M Ionescu  4
Affiliations
Case Reports

Clinical Aspects of Pterygium in the Presence of Cataract

M F Mercuţ Nicolcescu et al. Curr Health Sci J. 2019 Jul-Sep.

Abstract

Two of the most common UV-induced eye affections are pterygium and cataract. They are both defined as progressive diseases that impair patients' vision and share some common elements in their evolution process. The purpose of this study was to determine whether the presence of cataract influences the clinical signs and symptoms of patients with pterygium. Therefore, we have analyzed 84 patients with pterygium, among which 23 also presented cataract, as an overall study lot, as well as divided by age decades. We have determined that almost all patients with both pterygium and cataract declared extensive UV exposure in antecedents and have also reported a blurred vision. We found no correlation between the presence of cataract and the size of pterygium lesions, or symptoms like foreign body sensation, tearing or symblepharon.

Keywords: Pterygium; UV-induced eye lesions; cataract.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Distribution of the study lot by: a) pterygium lesion size and presence of cataract; b) age decades, presence of cataract and pterygium lesions mean size
Figure 2
Figure 2
Distribution of the study lot according to the presence of clinical manifestations
Figure 3
Figure 3
Distribution of the study lot for patients without blurred vision (a), and with blurred vision (b)
Figure 4
Figure 4
Distribution of the study lot according to general habits, divided by groups
Figure 5
Figure 5
Distribution of the study lot for patients without UV exposure (a), and with UV exposure (b) in antecedents
See this image and copyright information in PMC

References

    1. Garźon-Chaveza D, Quentind E, Harrison S, Parisi A, Butler H, Downs N. The geospatial relationship of pterygium and senile cataract to ambient solar ultraviolet in tropical Ecuador. Photochem Photobiol Sci. 2018;17(8):1075–1083. - PubMed
    1. Behar-Cohen F, Baillet G, de Ayguavives T. Ultraviolet damage to the eye revisited: eye-sun protection factor (E-SPF®), a new ultraviolet protection label for eyewear. Clin Ophthalmol. 2014;8:87–104. - PMC - PubMed
    1. Yam JC, Kwok AK. Ultraviolet light and ocular diseases. Int Ophthalmol. 2014;34(2):383–400. - PubMed
    1. Miyashita H, Hatsusaka N, Shibuya E, Mita N, Yamazaki M, Shibata T, Ishida H, Ukai Y, Kubo E, Sasaki H. Association between ultraviolet radiation exposure dose and cataract in Han people living in China and Taiwan: A cross-sectional study. PLoS ONE. 2018;14(4):e0215338–e0215338. - PMC - PubMed
    1. Hashemi H, Khabazkhoob M, Yekta A, Jafarzadehpour E, Ostadi Moghaddam H, Kangari H. The prevalence and determinants of pterygium in rural areas. Journal of Current Ophthalmology. 2016;29(3):194–198. - PMC - PubMed

Publication types

LinkOut - more resources